home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

The Potent New Anti-Tumor Immunotherapies

 
  June 16, 2006  
     
 


Keystone Symposia, Banff, Alberta, Canada
March 28 - April 2, 2007


For the first time, significant numbers of patients with some solid cancer histologies can be successfully treated using immunological means. Progress in our understanding of immune activation, homeostasis and regulation has reached a “tipping point” that has enabled the development of multiple anti-tumor immune-based strategies. Adoptive cell transfer (ACT) of anti-tumor T cells after the depletion host immune cells causes objective regression in about 50% of the patients. Work on therapeutic cancer vaccines is intensive and will actively be discussed at the meeting. The challenge now is to control and direct the potent new weapons in at the immunotherapist’s disposal. This meeting will bring the key scientists who are securing the basic foundations of the new immunology and the translational immunotherapists who are pioneering strategies that objectively work in the clinic.
 
 
Organized by: Nicholas P. Restifo
Invited Speakers: - Rafi Ahmed, Emory University School of Medicine
- Jacques Banchereau, Baylor Institute for Immunology Research
- Bruce Blazar, University of Minnesota
- Malcolm Brenner, Baylor College of Medicine
- Vincenzo Cerundolo, Institute of Molecular Medicine
- Lieping Chen, Johns Hopkins School of Medicine
- Mark Davis, Stanford University
- Michael Dustin, New York University School of Medicine
- Philip Greenberg, University of Washington
- Elizabeth Jaffee, Johns Hopkins University
- Carl June, University of Pennsylvania
- Hyam Levitsky, Johns Hopkins School of Medicine
- Andrew Mellor, Medical College of Georgia
- Rienk Offringa, Leiden University Medical Center
- Pamela Ohashi, Ontario Cancer Institute/University Health Network
- Drew Pardoll, Johns Hopkins School of Medicine
- Nicholas Restifo, National Institutes of Health
- Stanley Riddell, Fred Hutchinson Cancer Research Center
- Pedro Romero, Ludwig Institute for Cancer Research
- Steven Rosenberg, National Institutes of Health
- Federica Sallusto, coffman
- Stephen Schoenberger, La Jolla Institute for Allergy and Immunology
- Ton Schumacher, Netherlands Cancer Institute
- Andrey Shaw, Washington University
- Linda Sherman, The Scripps Research Institute
- Charles Surh, The Scripps Research Institute
- Juan Carlos Zúñiga-Pflücker, Sunnybrook Research Institute
 
Deadline for Abstracts: Nov. 28, 2006
 
Registration: Please see website
E-mail: info@keystonesymposia.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.